Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells

Oncotarget

Volumn 7, Issue 4, 2016, Pages 4110-4121

  Choi, Pui Wah ^a,b   Yang, Junzheng ^b   Ng, Shu Kay ^c   Feltmate, Colleen ^b   Muto, Michael G ^b   Hasselblatt, Kathleen ^b   Lafferty Whyte, Kyle ^d   JeBailey, Lellean ^d   MacConaill, Laura ^e   Welch, William R ^b   Fong, Wing Ping ^a   Berkowitz, Ross S ^b   Ng, Shu Wing ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c GRIFFITH UNIVERSITY   (Australia)

^d THOMSON REUTERS   (United Kingdom)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Collective movement; Inclusion cyst; Ovarian cancer; Three dimensional culture; Tumor invasion

Indexed keywords

COLLAGEN TYPE 1; LAMININ; LAMININ V; MICRORNA 200; MOLECULAR MARKER; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL MOTION; CONTROLLED STUDY; DOWN REGULATION; EPIDERMOID CYST; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROENVIRONMENT; OVARY CANCER; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; APOPTOSIS; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENE REGULATORY NETWORK; GENETICS; METABOLISM; OVARY; OVARY CYST; OVARY TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

APOPTOSIS; BIOMARKERS, TUMOR; CADHERINS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MICROSCOPY, FLUORESCENCE; OVARIAN CYSTS; OVARIAN NEOPLASMS; OVARY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84957999024     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6588     Document Type: Article

References (50)

1. Serov SF and Scullt RE. (1993). Histological typing of ovarian tumors. (Geneva: World Health Organization).
2. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ and Cronin KA. (2015). SEER Cancer Statistics Review, 1975-2012. National Cancer Institute, Bethesda, MD).
3. Fujita M, Enomoto T and Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol. 2003; 202:97-99.
4. Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474:609-615.
5. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I, Australian Ovarian Cancer Study G, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008; 14:5198-5208.
6. Cramer DW, Hutchison GB, Welch WR, Scully RE and Ryan KJ. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst. 1983; 71:711-716.
7. Holschneider CH and Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol. 2000; 19:3-10.
8. Tan OL, Hurst PR and Fleming JS. Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer? J Pathol. 2005; 205:483-490.
9. Feeley KM and Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology. 2001; 38:87-95.
10. Auersperg N, Maines-Bandiera SL and Dyck HG. Ovarian carcinogenesis and the biology of ovarian surface epithelium. J Cell Physiol. 1997; 173:261-265.
11. Scully RE. Pathology of ovarian cancer precursors. J Cell Biochem Suppl. 1995; 23:208-218.
12. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD and Crum CP. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007; 211:26-35.
13. Crum CP. Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol. 2009; 3:165-170.
14. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D and Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2005; 11:63-70.
15. Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER and Cho KR. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell. 2007; 11:321-333.
16. Wu R, Baker SJ, Hu TC, Norman KM, Fearon ER and Cho KR. Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer. Am J Pathol. 2013; 182:1391-1399.
17. Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN and Nikitin AY. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 2003; 63:3459-3463.
18. Meinhardt A, Eberle D, Tazaki A, Ranga A, Niesche M, Wilsch-Brauninger M, Stec A, Schackert G, Lutolf M and Tanaka EM. 3D reconstitution of the patterned neural tube from embryonic stem cells. Stem Cell Reports. 2014; 3:987-999.
19. Kuo IY, DesRochers TM, Kimmerling EP, Nguyen L, Ehrlich BE and Kaplan DL. Cyst formation following disruption of intracellular calcium signaling. Proc Natl Acad Sci U S A. 2014; 111:14283-14288.
20. Raza A, Ki CS and Lin CC. The influence of matrix properties on growth and morphogenesis of human pancreatic ductal epithelial cells in 3D. Biomaterials. 2013; 34:5117-5127.
21. Liu B, Li C, Liu Z, Dai Z and Tao Y. Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease. BMC Nephrol. 2012; 13:109.
22. Rizki A, Weaver VM, Lee SY, Rozenberg GI, Chin K, Myers CA, Bascom JL, Mott JD, Semeiks JR, Grate LR, Mian IS, Borowsky AD, Jensen RA, Idowu MO, Chen F, Chen DJ, et al. A human breast cell model of preinvasive to invasive transition. Cancer Res. 2008; 68:1378-1387.
23. Martin KJ, Patrick DR, Bissell MJ and Fournier MV. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE. 2008; 3:e2994.
24. Debnath J, Muthuswamy SK and Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003; 30:256-268.
25. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S and Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008; 9:582-589.
26. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10:593-601.
27. Tamura M, Sasano H, Suzuki T, Fukaya T, Watanabe T, Kusakabe M, Sakakura T and Yajima A. Distribution of tenascin in normal cycling human ovary. Hum Reprod. 1993; 8:2015-2018.
28. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell. 2000; 100:57-70.
29. Friedl P and Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol. 2009; 10:445-457.
30. Cheung KJ, Gabrielson E, Werb Z and Ewald AJ. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 2013; 155:1639-1651.
31. Hegerfeldt Y, Tusch M, Brocker EB and Friedl P. Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Res. 2002; 62:2125-2130.
32. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS and Friedl P. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol. 2007; 9:893-904.
33. Friedl P, Locker J, Sahai E and Segall JE. Classifying collective cancer cell invasion. Nat Cell Biol. 2012; 14:777-783.
34. Leighton J, Kalla RL, Turner JM, Jr. and Fennell RH, Jr. Pathogenesis of tumor invasion. II. Aggregate replication. Cancer Res. 1960; 20:575-586.
35. Rodriguez M and Dubeau L. Ovarian tumor development: insights from ovarian embryogenesis. Eur J Gynaecol Oncol. 2001; 22:175-183.
36. Van Niekerk CC, Ramaekers FC, Hanselaar AG, Aldeweireldt J and Poels LG. Changes in expression of differentiation markers between normal ovarian cells and derived tumors. Am J Pathol. 1993; 142:157-177.
37. Drapkin R, Crum CP and Hecht JL. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia. Hum Pathol. 2004; 35:1014-1021.
38. Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brannstrom M, Janson PO, Enerback S and Hedin L. E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer. 1997; 74:275-280.
39. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A and Roskelley CD. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A. 1999; 96:6249-6254.
40. Ong A, Maines-Bandiera SL, Roskelley CD and Auersperg N. An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int J Cancer. 2000; 85:430-437.
41. Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, Bahr JM and Hales DB. E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol. 2009; 113:362-369.
42. Hales KH, Speckman SC, Kurrey NK and Hales DB. Uncovering molecular events associated with the chemosuppressive effects of flaxseed: a microarray analysis of the laying hen model of ovarian cancer. BMC Genomics. 2014; 15:709.
43. Maines-Bandiera SL and Auersperg N. Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int J Gynecol Pathol. 1997; 16:250-255.
44. Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, van Nagell JR, Wang C, Chen L, Plattner R, Kaetzel DM, Luo J, et al. CD151-alpha3beta1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling. Oncotarget. 2014; 5:12203-12217. doi: 10.18632/oncotarget.2622.
45. Ip CK, Yung S, Chan TM, Tsao SW and Wong AS. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation. Oncotarget. 2014; 5:9133-9149. doi: 10.18632/oncotarget.2362.
46. Giampieri S, Manning C, Hooper S, Jones L, Hill CS and Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol. 2009; 11:1287-1296.
47. Lu M, Jolly MK, Onuchic J and Ben-Jacob E. Toward decoding the principles of cancer metastasis circuits. Cancer Res. 2014; 74:4574-4587.
48. Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC and Ng SW. Selenium binding protein 1 in ovarian cancer. Int J Cancer. 2006; 118:2433-2440.
49. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC and Berkowitz RS. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPVE6E7 ORFs). Exp Cell Res. 1995; 218:499-507.
50. Kaplan EL and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457-481.